Medically reviewed by Matthew Wosnitzer, MD Most prostate cancers eventually stop responding to androgen deprivation therapy ...

Gonadorelin, a synthetic analog of the gonadotropin-releasing hormone (GnRH), has garnered attention for its intriguing ...